| Aug 7 |
Wave Life Sciences Q2 2024 Earnings Preview
|
| Aug 7 |
Wave Life Sciences (NASDAQ:WVE investor five-year losses grow to 72% as the stock sheds US$72m this past week
|
| Aug 1 |
Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024
|
| Jun 27 |
Analysts Are Betting On Wave Life Sciences Ltd. (NASDAQ:WVE) With A Big Upgrade This Week
|
| Jun 26 |
Update: WAVE Life Sciences Discloses 'Positive' Phase 1b/2a Data From Huntington's Disease Treatment But Shares Fall on Neurofilament Concern
|
| Jun 25 |
What's Going On With Wave Life Sciences Stock On Tuesday?
|
| Jun 25 |
Wave jumps on trial data for Huntington’s disease therapy
|
| Jun 25 |
Wave, with new data, plots path forward for Huntington’s drug
|
| Jun 25 |
Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
|
| Jun 12 |
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
|
